Transcription of PRODUCT MONOGRAPH
{{id}} {{{paragraph}}}
Example: bankruptcy
PRODUCT MONOGRAPH
PRODUCT MONOGRAPH . SAXENDA . liraglutide 6 mg/mL. Solution for injection in a pre-filled pen Human Glucagon Like Peptide-1 (GLP-1). Weight Management Novo Nordisk Canada Inc. Date of Revision: 300-2680 Skymark Avenue Mississauga, Ontario 12 July 2017. L4W 5L6. Submission Control No: 197571. SAXENDA ( liraglutide ) Page 1 of 47. Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION .. 3. SUMMARY PRODUCT INFORMATION .. 3. 3. INDICATIONS AND CLINICAL USE .. 3. CONTRAINDICATIONS .. 4. WARNINGS AND PRECAUTIONS .. 4. ADVERSE 9. DRUG INTERACTIONS .. 14. DOSAGE AND ADMINISTRATION .. 16. OVERDOSAGE .. 17. ACTION AND CLINICAL PHARMACOLOGY .. 18. STORAGE AND STABILITY .. 20. SPECIAL HANDLING INSTRUCTIONS.
SAXENDA® (liraglutide) Page 1 of 47. PRODUCT MONOGRAPH. SAXENDA®. liraglutide . 6 mg/mL . Solution for Injection in a pre-filled pen . Human Glucagon Like Peptide-1 (GLP-1) Weight Management
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: